These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis. Calfon MA; Rosenthal A; Mallas G; Mauskapf A; Nudelman RN; Ntziachristos V; Jaffer FA J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847078 [TBL] [Abstract][Full Text] [Related]
7. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402 [TBL] [Abstract][Full Text] [Related]
8. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. Tawakol A; Migrino RQ; Bashian GG; Bedri S; Vermylen D; Cury RC; Yates D; LaMuraglia GM; Furie K; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ J Am Coll Cardiol; 2006 Nov; 48(9):1818-24. PubMed ID: 17084256 [TBL] [Abstract][Full Text] [Related]
9. Molecular Imaging of Matrix Metalloproteinase-2 in Atherosclerosis Using a Smart Multifunctional PET/MRI Nanoparticle. Tu Y; Ma X; Chen H; Fan Y; Jiang L; Zhang R; Cheng Z Int J Nanomedicine; 2022; 17():6773-6789. PubMed ID: 36600879 [TBL] [Abstract][Full Text] [Related]
10. Imaging vulnerable plaques by targeting inflammation in atherosclerosis using fluorescent-labeled dual-ligand microparticles of iron oxide and magnetic resonance imaging. Chan JMS; Monaco C; Wylezinska-Arridge M; Tremoleda JL; Cole JE; Goddard M; Cheung MSH; Bhakoo KK; Gibbs RGJ J Vasc Surg; 2018 May; 67(5):1571-1583.e3. PubMed ID: 28648478 [TBL] [Abstract][Full Text] [Related]
11. Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer Hyafil F; Pelisek J; Laitinen I; Schottelius M; Mohring M; Döring Y; van der Vorst EP; Kallmayer M; Steiger K; Poschenrieder A; Notni J; Fischer J; Baumgartner C; Rischpler C; Nekolla SG; Weber C; Eckstein HH; Wester HJ; Schwaiger M J Nucl Med; 2017 Mar; 58(3):499-506. PubMed ID: 27789718 [No Abstract] [Full Text] [Related]
12. Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using ( Varasteh Z; De Rose F; Mohanta S; Li Y; Zhang X; Miritsch B; Scafetta G; Yin C; Sager HB; Glasl S; Gorpas D; Habenicht AJR; Ntziachristos V; Weber WA; Bartolazzi A; Schwaiger M; D'Alessandria C Theranostics; 2021; 11(4):1864-1876. PubMed ID: 33408786 [No Abstract] [Full Text] [Related]
13. Comparison of the Diagnostic Performances of Ultrasound, High-Resolution Magnetic Resonance Imaging, and Positron Emission Tomography/Computed Tomography in a Rabbit Carotid Vulnerable Plaque Atherosclerosis Model. Xu L; Wang R; Liu H; Wang J; Liang W; Mang J; Xu Z J Ultrasound Med; 2020 Nov; 39(11):2201-2209. PubMed ID: 32395879 [TBL] [Abstract][Full Text] [Related]
17. Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis. Li W; Kornmark L; Jonasson L; Forssell C; Yuan XM Atherosclerosis; 2009 Jan; 202(1):92-102. PubMed ID: 18495127 [TBL] [Abstract][Full Text] [Related]
18. Novel PET Imaging of Atherosclerosis with 68Ga-Labeled NOTA-Neomannosylated Human Serum Albumin. Kim EJ; Kim S; Seo HS; Lee YJ; Eo JS; Jeong JM; Lee B; Kim JY; Park YM; Jeong M J Nucl Med; 2016 Nov; 57(11):1792-1797. PubMed ID: 27339872 [TBL] [Abstract][Full Text] [Related]